-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DbpckoMSgClo1/NozAQGmbyHsGOgo977/xVIpYCvp2y/s4TWnx8dnwVIyeMTR+yv 1SKhpCcEp6PsYcyIo0R6AA== 0001091726-02-000007.txt : 20021021 0001091726-02-000007.hdr.sgml : 20021021 20021021133255 ACCESSION NUMBER: 0001091726-02-000007 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20021021 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-53249 FILM NUMBER: 02793649 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VALOR CAPITAL MANAGEMENT LP CENTRAL INDEX KEY: 0001091726 IRS NUMBER: 133886687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 137 ROWAYTON AVE STREET 2: UNIT 100 CITY: ROWAYTON STATE: CT ZIP: 06853 BUSINESS PHONE: 2038545551 MAIL ADDRESS: STREET 1: 137 ROWAYTON AVE STREET 2: UNIT 100 CITY: ROWAYTON STATE: CT ZIP: 06853 SC 13G 1 ilgn.txt SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Rule 13d-102 Under the Securities Exchange Act of 1934 (Amendment No. )* Interleukin Genetics Inc - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 458738101 - -------------------------------------------------------------------------------- (CUSIP Number) 10/21/02 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1 (b) |x| Rule 13d-1 (c) |_| Rule 13d-1 (d) - ---------- * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 458738101 13G Page 2 of 2 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Valor Capital Management, L.P. 13-3886687 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |x| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 1,508,075 - -------------------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY OWNED BY - -------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 1,508,075 WITH - -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,508,075 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.2% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT Item 1. (a) The name of the issuer is Interleukin Genetics Inc ("The Issuer") (b) The principal executive office is located at 135 Beaver Street, 2nd floor, Waltham, MA 02452 Item 2. (a) The names of the persons filing this statement ("the statement") are Valor Capital Management, L.P., a Delaware limited partnership ("Valor Capital") (b) The Principal Business Office of the Filers is 137 Rowayton Ave., Rowayton, CT 06853 (c) For citizenship information see item 4 of the cover sheet of each Filer (d) This Statement relates to the Common Stock, $.001 par value of the Issuer (e) The CUSIP Number of the common stock of the Issuer is 458738101 Item 3. If this statement is filed pursuant to "240.13d-1(b), or (c), check whether the person filing is a: (a) _ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c) (b) _ Bank as defined in section 3 (a)(6) of the Act (15 U.S.C. 78c) (c) _ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C.78c) (d) _ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) _ An Investment adviser in accordance with "240.13d-1(b)(1)(ii)(E) (f) _ An employee benefit plan or endowment fund in accordance with "240.13d-1(b)(1)(ii)(F) (g) _ A parent holding company or control person in accordance with "240.13d-1(b)(1)(ii)(G) (h) _ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813) (i) _ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3) (j) _ Group, in accordance with "240.13d-1(b)(1(ii)(J) Item 4. Owwnership. See Items 5-9 and 11 on the cover page for each filer. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following _. Instruction: Dissolution of a group requires a response to this item. Item 6. Ownership of More than Five Percent on Behalf of Another Person. If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. If a parent holding company or control person has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach and exhibit stating the identity and the Item 3 classification of the relavant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relavant subsidiary. John M. Kratky III is the managing member and control person of KM. KM is the general partner and control person of Valor Capital. Valor Capital is an investment vehicle formed for the purpose of investing and trading in a wide variety of securities and financial instruments. _ Exhibit attached Item 8. Identification and classification of the Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(1)(ii)(J) so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d) attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. _ Exhibit attached Item 10. Certification (a) The following certification shall be included if the statement filed pursuant to "240.13d-1(b): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. The following certification shall be included if the statement filed pursuant to "240.13d-1(c)": (b) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated October 21, 2002 _____________________________ John M. Kratky III Valor Capital Management, LP By: Kratky Management, LLC General Partner ____________________________ John M. Kratky III, Managing Member -----END PRIVACY-ENHANCED MESSAGE-----